Actively Recruiting

Phase 1
Age: 45Years - 60Years
FEMALE
NCT04478305

Affect of Duavive on Mood & Anxiety Symptoms

Led by St. Joseph's Healthcare Hamilton · Updated on 2024-12-03

30

Participants Needed

1

Research Sites

73 weeks

Total Duration

On this page

Sponsors

S

St. Joseph's Healthcare Hamilton

Lead Sponsor

M

McMaster University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study evaluates the impact of conjugated estrogens/ bazedoxifene (CE/ BZA) on the mood (depression and anxiety) in peri- and early menopausal women.

CONDITIONS

Official Title

Affect of Duavive on Mood & Anxiety Symptoms

Who Can Participate

Age: 45Years - 60Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female between 45 and 60 years old
  • Able to communicate in English
  • In perimenopause as defined by WHO STRAW criteria or in early menopause within 10 years of final menstrual period
  • Experiencing depressive symptoms (score of 10 or higher on CES-D-10) and/or anxiety symptoms (score of 10 or higher on GAD-7)
Not Eligible

You will not qualify if you...

  • Personal history of breast, ovarian, or endometrial cancer or endometrial hyperplasia
  • Unexplained abnormal uterine bleeding
  • Active or past venous or arterial blood clots such as deep vein thrombosis, pulmonary embolism, stroke, heart attack, or coronary heart disease
  • Active liver disease
  • Known clotting disorders like protein C, protein S, or antithrombin deficiency
  • Known or suspected pregnancy, women who may become pregnant, or nursing mothers
  • Partial or complete vision loss due to eye blood vessel disease
  • Uncontrolled high blood pressure (systolic >160 mm Hg or diastolic >95 mm Hg)
  • Endocrine diseases affecting mood (excluding thyroid disease)
  • Active serious suicidal thoughts with intent
  • Symptoms of active psychosis
  • Daily use of antidepressant medication
  • Use of other psychoactive or central nervous system medications within 2 weeks before screening
  • Known allergy to conjugated estrogens or bazedoxifene

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St Joseph's Healthcare

Hamilton, Ontario, Canada, L8P 3B7

Actively Recruiting

Loading map...

Research Team

A

Alison Shea, MD

CONTACT

L

Leticia Hernandez Galan, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Affect of Duavive on Mood & Anxiety Symptoms | DecenTrialz